Chatbot rosie aims to cut postpartum depression in minority moms

NCT ID NCT06053515

Completed Knowledge-focused Sponsor: University of Maryland, College Park Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a free chatbot called Rosie that gives pregnant women and new moms instant, reliable health information from trusted sources. 400 minority women who were pregnant or had an infant under 6 months used the chatbot to ask questions and get answers. The goal was to see if this tool could reduce postpartum depression, emergency room visits, and improve attendance at well-baby checkups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Rosie the Chatbot (educational chatbot)
What this could lead to: If it works, this could point toward a simple, free tool to help new moms get reliable health answers and potentially reduce postpartum depression and unnecessary ER visits.
What could go wrong: This is a completed study with 400 participants, but results are not yet published. The chatbot provides information only, not medical care, so it may not change health outcomes on its own.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFANT CONDITIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFANT CONDITIONS INFANT DEVELOPMENT POSTPARTUM DEPRESSION PREGNANCY

Contacts and locations

Locations

University of Maryland

College Park, Maryland, 20742, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.